Shanghai Junshi (China) Investor Sentiment

688180 Stock   29.67  0.48  1.59%   
About 61% of Shanghai Junshi's investor base is looking to short. The analysis of the overall investor sentiment regarding Shanghai Junshi Biosciences suggests that many traders are alarmed. The current market sentiment, together with Shanghai Junshi's historical and current headlines, can help investors time the market. In addition, many technical investors use Shanghai Junshi Bios stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at news.google.com         
Shanghai Junshi Biosciences Has Debt But No Earnings Should You Worry - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Junshi Biosciences Shareholders Approve Key Resolutions - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
retail investors who own 51 percent along with institutions invested in Shanghai Junshi Biosciences ...
Google News at Macroaxis
over six months ago at news.google.com         
Junshi Biosciences Gears Up for 2023 AGM - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
Investors in Shanghai Junshi Biosciences from three years ago are still down 86, even after 22 perce...
Google News at Macroaxis
over six months ago at news.google.com         
Comparing Shanghai Junshi Biosciences and ImmunoGen - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Is Shanghai Junshi Biosciences Using Debt Sensibly - Simply Wall St
Google News at Macroaxis
over a year ago at news.google.com         
Shanghai Junshi Biosciences Full Year 2023 Earnings CN2.28 loss per share - Simply Wall St
Google News at Macroaxis
over a year ago at news.google.com         
Individual investors who hold 47 percent of Shanghai Junshi Biosciences Co., Ltd. gained 8.2, inside...
Google News at Macroaxis
over a year ago at news.google.com         
Individual investors who hold 47 percent of Shanghai Junshi Biosciences Co., Ltd. gained 8.2, inside...
Google News at Macroaxis
over a year ago at news.google.com         
Junshi Biosciences Announces Toripalimabs NDA Accepted by the Singapore Health Sciences Authority - ...
Google News at Macroaxis
over a year ago at news.google.com         
Shanghai Junshi Biosciences to Narrow Losses -January 31, 2024 at 0422 am EST - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Risks Still Elevated At These Prices As Shanghai Junshi Biosciences Co., Ltd. Shares Dive 29 percent...
Google News at Macroaxis
over a year ago at news.google.com         
Junshi Hopes New Scientist CEO Can Cure Its Woes - Seeking Alpha
Google News at Macroaxis
over a year ago at news.google.com         
Shanghai Junshi Biosciences Co., Ltd. and Topalliance Biosciences Inc Appoints Li Ning as Vice Chair...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Shanghai Junshi that are available to investors today. That information is available publicly through Shanghai media outlets and privately through word of mouth or via Shanghai internal channels. However, regardless of the origin, that massive amount of Shanghai data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Shanghai Junshi news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Shanghai Junshi relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Shanghai Junshi's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Shanghai Junshi alpha.

Shanghai Junshi Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Shanghai Junshi Biosciences Partners with LEO Pharma for European Expansion - TipRanks
01/20/2025

Complementary Tools for Shanghai Stock analysis

When running Shanghai Junshi's price analysis, check to measure Shanghai Junshi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Junshi is operating at the current time. Most of Shanghai Junshi's value examination focuses on studying past and present price action to predict the probability of Shanghai Junshi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Junshi's price. Additionally, you may evaluate how the addition of Shanghai Junshi to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stocks Directory
Find actively traded stocks across global markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios